ENPATH REPORTS FIRST HUMAN USE OF FASTAC FLEX.Enpath Medical, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :NPTH) has launched the FASTAC FLEX epicardial lead implant tool after the first human use of the FasTac(R) Flex tool occurred in April. This unique deflectable implant tool was used to place two MyoPore(R) sutureless bipolar epicardial leads, also manufactured by Enpath, on the left ventricle of a patient in completing the left ventricular lead segment of her cardiac resynchronization therapy (CRT (1) (C RunTime) See runtime library. (2) (Cathode Ray Tube) A vacuum tube used as a display screen in a computer monitor or TV. The viewing end of the tube is coated with phosphors, which emit light when struck by electrons. ) system. CRT is used in the treatment of heart failure and is one of the fastest growing segments within Cardiac Rhythm Management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. devices. Jose Navia, M.D., a Cardiothoracic Surgeon at The Cleveland Clinic, performed the surgical lead implant. Dr. Navia played a role in the iterative development and trial process of the FasTac Flex. "This tool enabled me to reach the epicardial epicardial pertaining to the visceral pericardium (epicardium) or to the epicardia. epicardial receptors receptors in the left ventricle adapted to respond to stretch and chemical stimulants. surface at the proper angle to easily place both leads into the myocardium myocardium /myo·car·di·um/ (-kahr´de-um) the middle and thickest layer of the heart wall, composed of cardiac muscle. hibernating myocardium see myocardial hibernation, under ," Dr. Navia said. "Enhancing precision and improving care is the goal." Dr. Navia is collaborating with multiple medical disciplines to treat heart failure at The Cleveland Clinic's Center for Electrical Therapies for Heart Failure. About Enpath Medical Enpath Medical, Inc., headquartered in Plymouth, Minnesota, is a leader in the design, development, manufacture and marketing of percutaneous delivery systems and stimulation leads technologies. Its products include venous vessel introducers, epicardial and endocardial endocardial /en·do·car·di·al/ (-kahr´de-al) 1. situated or occurring within the heart. 2. pertaining to the endocardium. endocardial 1. situated or occurring within the heart. 2. stimulation leads, safety needles and other products for use in pacemaker, defibrillator, catheter and infusion port procedures as well as neuromodulation and hearing restoration markets. Its products are sold worldwide through partnering relationships with other medical device companies. For more information, visit http://www.enpathmed.com or call 415/896-6820. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion